Continuous Treatment With Lenalidomide and Low-Dose Dexamethasone for Patients With Transplant-Ineligible Newly Diagnosed Multiple Myeloma in the First Trial: Impact of Age
Continuous Treatment With Lenalidomide and Low-Dose Dexamethasone for Patients With Transplant-Ineligible Newly Diagnosed Multiple Myeloma in the First Trial: Impact of Age
Languages of Item:
English
Abstract:
Empty abstract
Publication year:
2015
Authors:
Hulin, C Shustik, C Belch, A Petrucci, MT Dührsen, U Lu, J Song, K Rodon, P Garderet, L Hunter, H others
